Copyright
©The Author(s) 2016.
World J Respirol. Mar 28, 2016; 6(1): 14-23
Published online Mar 28, 2016. doi: 10.5320/wjr.v6.i1.14
Published online Mar 28, 2016. doi: 10.5320/wjr.v6.i1.14
Ref. | Type of study (number of patients) | Variables included in the model | Summary of results |
Gay et al[76] | Prospective (38) | HRCT score | HRCT fibrotic score ≥ 2: 80% sensitive and 85% specific in predicting death (34 mo average follow-up). The CRP does not add predicting value |
Pathology fibrotic score | |||
King et al[77] | Retrospective (91) | Age | Only prediction results of single variables are reported by the authors. No direct data about performance of the CRP are reported |
Smoking status | |||
Clubbing | |||
HRCT score | |||
HRCT score for PH | |||
TLC % pred | |||
PaO2 at max exercise | |||
Mogulkoc et al[78] | Retrospective (95) | HRCT score | HRCT and DLCO% combined model: AUC 0.91; sensitivity 84%, specificity 82% in predicting 2 yr survival |
DLCO % pred | |||
Wells et al[79] | Retrospective (212) | DLCO % pred | 5 yr survival CPI regression coefficient: 0.092 (0.043, 0.141). P < 0.0005 |
FVC % pred | |||
FEV1 % pred | |||
du Bois et al[80] | Prospective (830) | Age | Combined scoring system AUC: 0.75. 1 yr survival |
Respiratory hospitalization | |||
FVC % pred | |||
24 wk in FVC % pred | |||
Richards et al[29] | Prospective (241) | Gender | PCMI ≥ 330: AUC 0.74-0.84 in predicting survival. Average follow-up 1.8 yr |
FVC %pred | |||
DLCO %pred | |||
MMP-7 | |||
Mura et al[82] | Prospective (138) | MRCDS | ROSE > 2:HR 11.4, P < 0.0001; AUC 0.76; sensitivity 39%, specificity 100% in predicting survival. 3 yr follow-up |
6MWD % pred | |||
CPI | |||
Ley et al[83] | Retrospective (558) | Gender | GAP: c-index 69.3. Stages I, II and III 1-yr mortality of 6%, 16%, and 39%, respectively |
Age | |||
FVC % pred | |||
DLCO % pred |
Low risk (all of the following conditions) | Intermediate risk (1 or 2 of the following conditions) | High risk (all the following conditions) |
MRCDS ≤ 3 | MRCDS > 3 | MRCDS > 3 |
6MWD > 72% predicted | 6MWD 72% ≤ predicted | 6MWD 72% ≤ predicted |
CPI ≤ 41 | CPI > 41 | CPI > 41 |
Stage | I | II | III |
Points | 0-3 | 4-5 | 6-8 |
Predictor | Points | ||
Gender | |||
G | Female | 0 | |
Male | 1 | ||
Age | |||
A | ≤ 60 | 0 | |
61-65 | 1 | ||
≥ 65 | 3 | ||
FVC% predicted | |||
> 75 | 0 | ||
50-75 | 1 | ||
P | < 50 | 2 | |
DLCO% predicted | |||
> 55 | 0 | ||
36-55 | 1 | ||
≤ 35 | 2 | ||
Cannot perform | 3 | ||
Total possible points | 8 |
- Citation: Puxeddu E, Rogliani P. Prognostic scoring systems for clinical course and survival in idiopathic pulmonary fibrosis. World J Respirol 2016; 6(1): 14-23
- URL: https://www.wjgnet.com/2218-6255/full/v6/i1/14.htm
- DOI: https://dx.doi.org/10.5320/wjr.v6.i1.14